Kaitlin Ferguson is a pharmacist who is specialized in Critical Care in Maywood, Illinois. Patients can reach her at 2160 S 1st Ave, Maywood or contact her on 708-216-3875. Active license number of Kaitlin Ferguson is 051.299640 for Critical Care in Illinois. Kaitlin Ferguson is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Kaitlin Ferguson speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kaitlin Ferguson
Specialization:
Critical Care
Credentials:
PHARMD
Gender:
Female
Location:
2160 S 1st Ave, Maywood, Illinois, 60153-3328
Phone:
708-216-3875
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kaitlin Ferguson are as mentioned below.
NPI Number:
1528687522
NPI Enumeration Date:
10 Apr, 2020
NPI Last Update On:
10 Apr, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kaitlin Ferguson are as mentioned below.
Specialization
License Number
State
Status
Critical Care
051.299640
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2160 S 1st Ave, Maywood, Illinois
Zip:
60153-3328
Phone Number:
--
Fax Number:
--
Patients can reach Kaitlin Ferguson at 2160 S 1st Ave, Maywood, Illinois or can call on phone at 708-216-3875.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.